To determine whether blocked HS chains on GPC3 could affect cell migration, we treated HCC cells with HS20, a human monoclonal antibody that recognizes the HS chains on GPC3 [9], and then analyzed cell migration and motility. The gene discussed is GPC3; the disease is hepatocellular carcinoma.